• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:王文杰,朱洪峰,王建龙.芪冬颐心口服液辅助治疗小儿重症肺炎合并心力衰竭疗效观察[J].药学研究,2016,35(8):488-490[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3566次   下载 3114次 本文二维码信息
码上扫一扫!
芪冬颐心口服液辅助治疗小儿重症肺炎合并心力衰竭疗效观察
王文杰,朱洪峰,王建龙
字体:加大+|默认|缩小-
(济宁市第一人民医院儿童抢救室,山东 济宁 272000)
摘要:
目的 了解芪冬颐心口服液辅助治疗小儿重症肺炎合并心力衰竭的疗效。方法 选取2013~2015年收治的重症肺炎合并心力衰竭患儿76例,随机选取数字分为观察组、对照组各38例,对照组给予西药常规强心、利尿、抗感染、止咳祛痰等综合治疗,观察组在上述基础上加用中药芪冬颐心口服液口服辅助治疗。治疗前后采用彩色多普勒血流仪测定两组患儿左心室射血分数(LVEF) 、左心室缩短分数(LVSF)、心脏舒张早期心室充盈速度/舒张晚期心室充盈速度(E/A)。测血清氨基N末端B型利钠肽前体(NT-proBNP)、心肌酶谱(CK、CK-MB、LDH)变化。结果 观察组患儿肺啰音消失时间、心衰纠正时间、憋喘消失时间、平均住院时间均优于对照组,差异有统计学意义(P<0.05) 。观察组治疗后LVEF、LVSF、E/A 改善效果优于对照组,差异有统计学意义(P<0.05) 。观察组治疗后,NT-proBNP、心肌酶谱 各指标显著低于对照组,差异有统计学意义(P<0.05) 。结论 芪冬颐心口服液辅助治疗肺炎合并心力衰竭患儿,能够提高心肌收缩力、保护心肌细胞,有效改善心功能,有利于患儿预后,临床疗效较好。
关键词:  芪冬颐心口服液;重症肺炎;心力衰竭  检测
DOI:10.13506/j.cnki.jpr.2016.08.014
基金项目:
Clinical effects of Qidong Yixin Oral Solution for the auxiliary treatment of severe pneumonia complicated heart failure in children
WANG Wenjie,ZHU Hongfeng,WANG Jianlong
(Children's First Aid Room,Jining First People's Hospital,Jining 272000,China)
Abstract:
Objective To observe the clinical effects of Qidong Yixin Oral Solution for the auxiliary treatment of severe pneumonia complicated heart failure in children.Methods 76 cases of children with severe pneumonia complicated heart failure from 2013 to 2015 were selected,and randomly divided them into the observation group and the control group on average.The control group was treated with strong heart,diuresis,anti-infection,relieving cough and phlegm and other comprehensive treatment by western medicine.On the basis of the above treatment,the oral adjuvant therapy Qidong Yixin Oral Solution was carried out in the observation group.LVEF,LVSF,E/A of two groups of children were determined by color Doppler flow imaging before and after treatment.The changes of NT-proBNP and myocardial enzymes(CK,CK-MB,LDH) were detected.Results In the aspects of pulmonary rales,correction time of heart failure,breath holding time and average length of stay of children,the observation group were better than the control group,and the differences are statistically significant (P<0.05).The observation group were better than the control group in the improvement effect of LVEF,LVDD,E/A after treatment,and the differences were statistically significant (P<0.05).Each index of the observation group after treatment was significantly lower than the control group,such as NT-proBNP,myocardial enzyme spectrum,and the difference was statistically significant(P<0.05).Conclusion The method of Qidong Yixin Oral Solution for the auxiliary treatment of severe pneumonia complicated heart failure in children can improve the myocardial contractile force,protect the cardiac muscle cells and improve the cardiac function,which was beneficial to the prognosis of the patients with good clinical effect.
Key words:  Qidong Yixin Oral Solution  Severe pneumonia  Heart failure  Detection
今日访问量:2484    总访问量:55338922
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司